SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Cleveland-Cliffs, Inc. is a flat-rolled steel company, which engages in provision of iron ore pellets to the North American steel industry. It focuses on the production of metallic and coke, iron making, steelmaking, rolling and finishing, and downstream tubular components, stamping, and tooling. It operates through the Steelmaking and Other Businesses segments. The company was founded in 1847 and is headquartered in Cleveland, OH.

Cleveland-Cliffs Inc

A stronger-than-expected third-quarter report and managements upbeat 2027 outlook have driven CLFs sharp rally, with bullish traders focused on improved steel pricing and possible short covering. Others question whether the outlook can overcome the companys debt and execution concerns, and some view the move as a sell-the-news bounce.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

Goldman Sachs upgrade to Buy after a sharp selloff fueled hopes of a rebound, but traders debated whether the upgrade could overcome ongoing financing concerns, especially as the rally faded. Bulls point to AI demand, customer commitments and Nvidias support, while bears remain focused on CoreWeaves heavy debt burden and borrowing costs.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

The FDAs early expansion of ANKTIVA plus BCG to papillary-only BCG-unresponsive bladder cancer, alongside long-term data showing durable responses, is driving discussion about a larger patient market and future sales. Traders are puzzled by the share-price decline despite the positive developments, debating a sell-the-news reaction and broader biotech weakness versus unverified claims of short-selling or options-related pressure.

Cerebras Systems, Inc. engages in the designing and provision of processors for artificial intelligence (AI) training and inference. Its products include inference, Wafer Scale Engine, AI supercomputers, AI model services, cloud, systems, and processors. The company was founded by Sean Lie, Andrew D. Feldman, Gary Lauterbach, Michael James, and Jean Philippe Fricker in 2015 and is headquartered in Sunnyvale, CA.

Cerebras Systems Inc - Ordinary Shares - Class A

Cerebras Systems Inc

Cerebras shares are under heavy pressure amid IPO lockup-related selling concerns and a broader AI and semiconductor pullback, with traders also questioning the companys valuation, growth, and ability to scale. Bears expect further downside as more shares become eligible for sale, while bulls view the selloff as excessive and are averaging in.

Sea Ltd. is an internet and mobile platform company, which engages in the provision of online gaming services. It operates through the following segments: Digital Entertainment, E-Commerce, and Digital Financial Services. The Digital Entertainment segment offers and develops mobile and PC online games. The E-Commerce segment manages a third-party marketplace through the Shopee mobile app and websites that connect buyers and sellers. The Digital Financial Services segment includes a variety of payment services and loans to individuals and businesses through SeaMoney. Sea was founded by Xiao Dong Li, Gang Ye, and Jing Ye Chen on May 8, 2009 and is headquartered in Singapore.

Sea Ltd - ADR

Sea shares are under pressure amid a sharp pullback, with traders pointing to repeated insider sales and a reported DBS downgrade as potential reasons for the weakness; some also cite broader Indonesia and Southeast Asia market concerns. Bulls argue the selling was planned and the business remains strong, while bears see insider selling and weak price action as warning signs.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including sellers, advertising, and subscription services through internationally focused online stores. The AWS segment is composed of global sales of computers, storage, databases, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazons advance is drawing attention after Morgan Stanley named it a top pick, citing AWS growth, AI opportunities and warehouse automation as potential catalysts. Traders are broadly bullish on the move, though some remain cautious about heavy AI spending and whether the shares can sustain gains ahead of earnings.

Disc Medicine, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of treatments for hematologic diseases. It assembles a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. The company was founded in October 2017 and is headquartered in Watertown, MA.

Disc Medicine Inc

Disc Medicine shares are surging after bitopertin met all primary and secondary endpoints in the Phase 3 APOLLO trial for erythropoietic protoporphyria, supporting a planned FDA resubmission. Traders are broadly reacting positively, while debating short-squeeze potential and flagging dizziness and sharp price swings as concerns.

X-Energy, Inc. engages in the development of advanced small modular nuclear reactors and fuel technology for clean energy generation. Its solutions include Xe-100 and TRISO-X. The company was founded by Kam Ghaffarian and Eben Mulder in 2009 and is headquartered in Rockville, MD.

X-Energy Inc. - Ordinary Shares- Class A

X-Energy Inc

Sharp post-IPO selling and volatile trading dominate the discussion, with traders pointing to lockup-related supply, bearish analyst coverage, and weakness across nuclear stocks as possible pressures. Bulls are treating the pullback as an opportunity, citing Amazons backing and X-energys potential role in meeting future data-center power demand, while others stress that reactor commercialization remains years away.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius is drawing attention after a sharp selloff alongside other AI neocloud stocks, as traders debate financing costs and whether the sectors growth can justify its heavy capital needs. Some see the rebound and analyst support as a buying opportunity, while others call it a short-lived bounce and expect more pressure.

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

ALPHA TAU MEDICAL LTD

Attention centers on the FDA-cleared expansion of Alpha Taus REGAIN trial for recurrent glioblastoma and anticipated clinical data at the SNO meeting. Traders are bullish on early tumor-control findings and the broader pipeline, though some note the evidence comes from a small initial cohort.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Should Vanguard Russell 2000 Index Fund ETF Shares (VTWO) Be on Your Investing Radar?

Strive's Matt Cole Says Bitcoin Could Hit $500,000 By The End Of 2030 

Equity

Matt Cole expects a new Bitcoin bull market within the next 18 months, driven by a weaker dollar.


BULL Stock Slips Ahead Of Q1 Results: CEO Says Retail Traders Spreading Out AI Bets Beyond Megacaps

Webull CEO Anthony Denier told Investing.com that retail investors are expanding their AI bets across the broader semiconductor ecosystem.

Dave & Buster’s Stock Falls 3% After Q4 Earnings Miss

PLAY’s Q4 revenue of $529.6 million decreased 0.9% from the fourth quarter of fiscal 2024.


J. Jill Stock Slumps 26% Today – Why Such A Selloff?

JILL’s net sales for the fourth quarter of fiscal 2025 decreased 3.1% to $138.4 million year-over-year. 


BitGo Stock Up In After Hours After More Than 400% Jump In Q4 Revenue

BTGO reported total revenue of $6.2 billion in Q4 that increased 439.9% year-over-year, driven by higher digital asset trading activity. 


Apollo Reportedly Caps Private Credit Fund Withdrawals; Stock Dives

The $25 billion business development company, Apollo Debt Solutions, capped withdrawals at 5% of outstanding shares Monday after clients sought to redeem 11.2%, according to a report from Bloomberg News. 


Vanguard Scottsdale Funds - Vanguard Russell 2000 Index ETF

Bullish Sentiment

<ul class="summary-bullets"><li>Cole called Bitcoin's 2024 to 2025 rally "a very disappointing bull market," saying it failed to outperform gold.&nbsp;</li><li>He said the latest downturn was mild, with a drop of about 50% rather than the 80% seen in the past cycles.&nbsp;</li><li>ASST flashed a golden cross in early September, with its 50-day moving average moving above the 200-day.</li></ul>Strive, Inc. (ASST) stock edged higher during pre-market trading on Tuesday after Chief Executive Officer Matt Cole said that Bitcoin (BTC) could reach $500,000 by the end of 2030 and that its next bull market will be "substantially better" than the 2024-2025 run.&nbsp;During an<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.youtube.com/watch?v=waPbWM2D0kg">&nbsp;interview</a> with What Bitcoin Did, Cole explained that “Bitcoin might be 500K by the end of 2030." That would be nearly six times Bitcoin's current price from the $86,000 level.He added that Strive's thesis of about 50% compound annual growth would put Bitcoin back at its all-time high late next year. According to Cole, such growth would not be linear, and he further added that investors often focus too much on the short term and underestimate how returns build over time.&nbsp;<h2 class="st-heading-2">Where Bitcoin Fell Short</h2>Talking about Bitcoin’s latest rally, Cole called it "a very disappointing bull market for any Bitcoin bull." Simply put, while Bitcoin rose, it failed to outperform gold over that period. He said Bitcoin should have been the "fastest horse," meaning the best-performing asset, since it's an emerging form of money. Bitcoin bulls had to admit that the thesis did not play out, he added.&nbsp;<a href="https://stocktwits.com/coins/bitcoin">Bitcoin’s price</a> was up 0.2% over the past 24 hours. On Stocktwits, the retail sentiment around Bitcoin remained in the ‘neutral’ zone with chatter at ‘low’ levels over the last day.<h2 class="st-heading-2">Weaker Dollar, Milder Crashes</h2>Cole expected Bitcoin to enter a new bull market within the next 18 months. He tied that view to the U.S. debt load. He said the government had little room to cut spending, which left a weaker dollar as the likely way out. The CEO expected the biggest decline in the dollar's value in Bitcoin's history over the next three to seven years, as measured by the U.S. Dollar Index (DXY). This also comes as the dollar hit an 18-month high on Tuesday.However, Cole explained that “I have not called, actually, for the failure of the dollar,” he said. "What I’ve called for publicly is a massively devalued dollar."&nbsp;Cole also said the latest downturn was mild for Bitcoin, with a drop of about 50% rather than the 80% seen in past cycles. He described the current period as a "super cycle" with smaller crashes than earlier cycles.&nbsp;<h2 class="st-heading-2">ASST’s Second Golden Cross</h2><a href="https://stocktwits.com/symbol/ASST">ASST stock</a> rose over 1% in the pre-market. On Stocktwits, the retail sentiment around ASST remained in the ‘bearish’ zone, as chatter remained at ‘low’ levels over the last day.Last month, ASST stock formed a golden cross, a bullish technical signal in which its 50-day moving average (DMA) moved above its 200-day moving average (200-DMA).&nbsp;<figure class="image"><img src="https://news.stocktwits-cdn.com/koyfin_20261006_084830844_e4757ccf59.png" alt="koyfin_20261006_084830844.png" width="3600" height="1860"><figcaption>Strive Golden Cross As 50-Day SMA Moves Above 200-Day. Source: Koyfin</figcaption></figure>Traders often treat it as a sign that momentum is turning, but it does not guarantee more gains.ASST is up over 155% so far this year, and has lost around 41% in the last 12 months.Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/cryptocurrency/bitcoin-beat-td-cowen-forecast/cZDtTLSRBku">Bitcoin Beat The Forecast, But TD Cowen Reportedly Says The Rally May Have Further To Run</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, a smartphone displays the logo of Strive Inc. (NASDAQ: ASST), an American asset management company focused on investment products and strategies, in front of a screen showing the company's latest stock market chart on July 29, 2026 in Shenzhen, Guangdong Province, China. (Photo illustration by Cheng Xin/Getty Images)

Strive, Inc. (ASST) stock edged higher during pre-market trading on Tuesday after Chief Executive Officer Matt Cole said that Bitcoin (BTC) could reach $500,000 by the end of 2030 and that its next bull market will be "substantially better" than the 2024-

Strive's Matt Cole Says Bitcoin Could Hit $500,000 By The End Of 2030

Strive Inc.

T-REX 2X Long ASST Daily Target ETF

iShares Russell 2000 ETF

Vanguard Russell 2000 ETF

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Fundamentals

Info

VTWO News